1-4 of 4
Samuel Strober
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Development of immunosuppressive myeloid cells to induce tolerance in solid organ and hematopoietic cell transplant recipients

Clinical Trials & Observations
Kent P. Jensen, David A. Hongo, XuHuai Ji, PingPing Zheng, Rahul D. Pawar, Thomas Hsin-Hsu Wu, Stephan Busque, John D. Scandling, Judith A. Shizuru, Robert Lowsky, Asha Shori, Suparna Dutt, Jeffrey Waters, Anirudh Saraswathula, Jeanette Baker, John S. Tamaresis, Philip Lavori, Robert Negrin, Holden Maecker, Edgar G. Engleman, Everett Meyer, Samuel Strober
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3290–3302.
https://doi.org/10.1182/bloodadvances.2020003669
Published: 2021
Includes: Supplemental data
Journal Articles

Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohort

Clinical Trials & Observations
Michael A. Spinner, Vanessa E. Kennedy, John S. Tamaresis, Philip W. Lavori, Sally Arai, Laura J. Johnston, Everett H. Meyer, David B. Miklos, Lori S. Muffly, Robert S. Negrin, Andrew R. Rezvani, Judith A. Shizuru, Wen-Kai Weng, Richard T. Hoppe, Samuel Strober, Robert Lowsky
Journal: Blood Advances
Blood Adv (2019) 3 (16): 2454–2464.
https://doi.org/10.1182/bloodadvances.2019000297
Published: 2019
Includes: Supplemental data
Journal Articles

Accelerated, but not conventional, radiotherapy of murine B-cell lymphoma induces potent T cell–mediated remissions

Suparna Dutt, Michelle B. Atallah, Yoshitaka Minamida, Alexander Filatenkov, Kent P. Jensen, Bettina P. Iliopoulou, Rasa Tamosiuniene, Jeffrey Waters, Edgar G. Engleman, Samuel Strober
Journal: Blood Advances
Blood Adv (2018) 2 (19): 2568–2580.
https://doi.org/10.1182/bloodadvances.2018023119
Published: 2018
Includes: Supplemental data
Journal Articles

HLA-mismatched unrelated donor transplantation using TLI-ATG conditioning has a low risk of GVHD and potent antitumor activity

Clinical Trials & Observations
Michael A. Spinner, Marcelo Fernández-Viña, Lisa E. Creary, Olivia Quinn, Linda Elder, Sally Arai, Laura J. Johnston, Everett H. Meyer, David B. Miklos, Lori S. Muffly, Robert S. Negrin, Judith A. Shizuru, Wen-Kai Weng, Ginna G. Laport, Samuel Strober, Robert Lowsky, Andrew R. Rezvani
Journal: Blood Advances
Blood Adv (2017) 1 (17): 1347–1357.
https://doi.org/10.1182/bloodadvances.2017007716
Published: 2017
Includes: Supplemental data